Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining a lipophilicity window for the antimicrobial activity of 7-Alkoxy-3-Amino coumarin amphiphiles.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Computer-Aided Design of <i>Plasmodium chabaudi</i>-Derived Peptides with Dual Antibiofilm and Anti-inflammatory Activities.

ACS medicinal chemistry letters·2026
Same author

Site-specific protein and peptide modification by redeploying an asparaginyl ligase for noncanonical reactions.

Nature protocols·2026
Same author

Enzyme-Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors.

Chembiochem : a European journal of chemical biology·2026
Same author

Rational Design of Plant-Derived Protein Ligases with Altered Substrate Specificity.

Biochemistry·2026
Same author

Progress and Challenges in the Biosynthesis and Chemical Synthesis of Lasso Peptides.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Feb 25, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.

Sónia Troeira Henriques1, Nicole Lawrence1, Stephanie Chaousis1

  • 1Institute for Molecular Bioscience, The University of Queensland , Brisbane, Queensland 4072, Australia.

ACS Chemical Biology
|July 26, 2017
PubMed
Summary

Spider peptide gomesin analogues show enhanced antimicrobial activity and selective cancer cell membrane disruption. These findings highlight peptide potential for developing new antimicrobial and anticancer therapies targeting cancer cell membranes.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

2.0K

Related Experiment Videos

Last Updated: Feb 25, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

2.0K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Gomesin, an antimicrobial peptide from Acanthoscurria gomesiana spider, exhibits potent activity against Gram-negative bacteria and selective anticancer properties against melanoma.
  • A previously developed backbone cyclized analogue of gomesin demonstrated comparable activity and improved stability.
  • Current research aims to enhance cyclic gomesin's antimicrobial efficacy, understand its melanoma cell selectivity, and elucidate its mechanisms of action.

Purpose of the Study:

  • To design and synthesize novel cyclic gomesin analogues with improved antimicrobial properties.
  • To evaluate the selectivity of these analogues towards cancer cells versus normal cells.
  • To investigate the mode of action, including membrane binding and disruption capabilities.

Main Methods:

  • Synthesis and rational design of cyclic gomesin analogues.
  • Antimicrobial assays against Gram-negative and Gram-positive bacteria.
  • Cytotoxicity assays using cancer cell lines (melanoma, leukemia) and human red blood cells.
  • Membrane binding affinity studies and cell/model membrane disruption assays.

Main Results:

  • Optimized cyclic gomesin analogues exhibited approximately 10-fold increased antimicrobial activity against tested bacteria.
  • Enhanced analogues showed no increased toxicity to human red blood cells.
  • Gomesin and its analogues demonstrated higher toxicity towards melanoma and leukemia cells compared to red blood cells.
  • Peptides selectively targeted and disrupted cancer cell membranes, with selectivity influenced by membrane properties.

Conclusions:

  • Cyclic gomesin analogues represent promising leads for developing novel antimicrobial and anticancer agents.
  • Selective targeting and disruption of cancer cell membranes is a viable strategy for drug development.
  • Further research into peptide-membrane interactions can optimize therapeutic potential.